Facebook
X
LinkedIn
ForwardDate & Time of Session - 11/20/25 - from 12-1PM
Overview
Cyanokit (hydroxocobalamin) was the most common medication used to treat vasoplegia at UofL Health until a shortage occurred in November of 2024. Methylene blue and thiamine are alternatives that are used to treat vasoplegia. Vasoplegia, or vasoplegia syndrome, is a complex condition that may occur after cardiopulmonary bypass surgeries and can be difficult to treat. An in-depth review of primary literature and guidelines used to treat vasoplegia is critical for pharmacists to understand medication options available to treat patients.
Objectives
Upon completion of this activity, the participant will be able to:
1. Describe the pathophysiology and etiology of vasoplegia
2. Review the mechanisms of action of methylene blue, hydroxocobalamin, and thiamine when treating vasoplegia.
3. Investigate the literature and benefits of using agents to treat vasoplegia
4. Develop an appropriate treatment regimen for vasoplegia
Speakers
Abby Maurer, PharmD
PGY2 Critical Care Pharmacy Resident
UofL Health – Louisville, Kentucky
- 1.00 ACPE
In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.
This knowledge-based activity will award 1.00 contact hour(s) (0.100 CEUs) of continuing pharmacy education credit in states that recognize ACPE providers.